Irinotecan Liposome (Onivyde)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irinotecan Liposome (Onivyde), covering 2024-12-30 to 2024-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy [Phase 2]